<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=461926130648047&ev=PageView&noscript=1">

EUA granted for NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Assay

Detect SARS-CoV-2 and 3 other pathogens with one NeuMoDx test.

As COVID-19 continues to affect our everyday lives, it becomes more critical for patients to know if they are infected with SARS-CoV-2 or a different pathogen.

Get the latest

NeuMoDx Assay Menu

Blood Borne Viruses

HIV-1
HCV
HBV

Transplant

EBV
CMV
BKV
HSV I/II*
VZV*
HHV6*

Sexual & Reproductive Health

HPV
CT/NG
TV/MG
MG Resistance*

Respiratory

SARS-CoV-2
Flu A/B/RSV/SARS-CoV2
Flu A/B/RSV

Laboratory Developed Tests

RNA
DNA

Other

GBS
Strep A/C/G

*In development

See more details

Transform your lab with NeuMoDx



Ultra-fast integrated PCR with true random access and an unprecedented streamlined workflow

  • The industry’s first true random access capability that is scalable according to the needs of your laboratory
  • The ability for your laboratory to handle medium, high and ultra-high throughput testing needs
  • The flexibility your lab needs with assays and room temperature reagent storage together

Set up a NeuMoDx Demo

Learn more about NeuMoDx — a revolutionary molecular diagnostic solution

Critical decisions for patient care are dependent on accurate and timely clinical laboratory results. To meet this demand, your lab needs full automation, faster turnaround times, scalability, and streamlined workflows. NeuMoDx systems address these needs – and more.

Download brochure

Contact us

Connect with a specialist to learn more about NeuMoDx or set up a demo for your lab.

Product availability may vary by country specific regulatory requirements and approvals. Contact your country representative for further details.

The NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Assay is intended for in vitro diagnostic use.
In the United States:

Thank you for visiting NeuMoDx page.

Best regards,
Your NeuMoDx team

You have no access to content.